Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Growth differentiation factor 15 as mortality predictor in heart failure patients with non‐reduced ejection fraction
Authors
Keywords
-
Journal
ESC Heart Failure
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-06-27
DOI
10.1002/ehf2.12621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance
- (2018) Monika Gawor et al. BIOMARKERS
- Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction
- (2018) Pedro Moliner et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF
- (2018) Gianluigi Savarese et al. JACC-Heart Failure
- Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
- (2016) Kai C. Wollert et al. CLINICAL CHEMISTRY
- The incremental prognostic and clinical value of multiple novel biomarkers in heart failure
- (2016) Colette E. Jackson et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN JOURNAL OF HEART FAILURE
- Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction
- (2015) Michelle M.Y. Chan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF
- (2015) Si-Hyuck Kang et al. HEART
- The middle child in heart failure: heart failure with mid-range ejection fraction (40-50%)
- (2014) Carolyn S.P. Lam et al. EUROPEAN JOURNAL OF HEART FAILURE
- Factors Influencing the Predictive Power of Models for Predicting Mortality and/or Heart Failure Hospitalization in Patients With Heart Failure
- (2014) Wouter Ouwerkerk et al. JACC-Heart Failure
- Incremental Prognostic Power of Novel Biomarkers (Growth-Differentiation Factor-15, High-Sensitivity C-Reactive Protein, Galectin-3, and High-Sensitivity Troponin-T) in Patients With Advanced Chronic Heart Failure
- (2013) Dirk J. Lok et al. AMERICAN JOURNAL OF CARDIOLOGY
- Growth Differentiation Factor-15 Is a Useful Prognostic Marker in Patients With Heart Failure With Preserved Ejection Fraction
- (2013) Yasuhiro Izumiya et al. CANADIAN JOURNAL OF CARDIOLOGY
- Growth-differentiation factor-15 improves reclassification for the diagnosis of heart failure with normal ejection fraction in morbid obesity
- (2012) Andrea Baessler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study
- (2012) John G.F. Cleland et al. EUROPEAN JOURNAL OF HEART FAILURE
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
- (2012) et al. EUROPEAN JOURNAL OF HEART FAILURE
- The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction
- (2010) Raoul Stahrenberg et al. EUROPEAN JOURNAL OF HEART FAILURE
- Macrophage inhibitory cytokine MIC-1 is upregulated by short-wavelength light in cultured normal human dermal fibroblasts
- (2009) Masashi Akiyama et al. FEBS LETTERS
- State of the art: Using natriuretic peptide levels in clinical practice
- (2008) Alan Maisel et al. EUROPEAN JOURNAL OF HEART FAILURE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More